The Phoenix Pro, also known as The Phoenix Him, is a clinical strength FDA-Recognized at-home acoustic wave device that helps enhance bedroom performance for men with erectile dysfunction (ED)**. Using patented technology, The Phoenix Pro has a high success rate and is the most effective at-home device to help optimize your sexual performance.

Using sound waves, The Phoenix Pro improves blood flow to the penis, removes microplaque, and stimulates the growth of new blood vessels. Use of the Phoenix Pro also increases penile sensitivity and decreases refractory time.

Dr. Oak will guide you through the custom protocol that best fits your needs and will virtually meet with you several times during the course of treatment.

As a certified clinical sexologist, Dr. Oak is the only certified non-medical doctor in the US providing at-home treatment for ED with the Phoenix Pro.

No surgery. No pills. No injections. No physician office visits. Reach out to Dr. Oak to schedule a complimentary consultation today. Help is just a phone call away.

** Research Studies

• The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction.

• Evaluation of clinical efficacy, safety, and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial.

• Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies.

• Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.

• Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial.

• Low-intensity shock wave therapy for erectile dysfunction and the influence of disease duration.

• Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors